Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany - Marz, W; Dippel, F W; Theobald, K (Atherosclerosis, 2018)